amifostine anhydrous has been researched along with Cerebral Primitive Neuroectodermal Tumor in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorris, K | 1 |
| Fouladi, M | 1 |
| Davies, SM | 1 |
| Perentesis, JP | 1 |
| Lawrence, JM | 1 |
| Chow, LM | 1 |
| Assa'ad, A | 1 |
| Uygungil, B | 1 |
| Jodele, S | 1 |
1 other study available for amifostine anhydrous and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Crania | 2011 |